Fabien Forest

Toulouse University Hospital

France

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

30%

Cell Biology

40%

Cancer Biology

60%

Oncology

40%

Lung Disease

30%

Kinase Biology

20%

Bronchoscopy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms

Article Link

Year:

2024

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study

Article Link

Year:

2024

Abstract 1221: Selective translational activation of PBK (PDZ- binding kinase) reveals a molecular vulnerability of drug-tolerant persister cells to targeted therapies in EGFR-mutant lung adenocarcinoma

Article Link

Year:

2024

Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18F-FDG PET/CT

Article Link

Year:

2024

Spread Through Air Spaces in Stage I to III Resected Lung Adenocarcinomas

Article Link

Year:

2024

Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognizable by a specific epigenetic signature

Article Link

Year:

2023

Usefulness of an RNA extraction-free test for the multiplexed detection of ALK , ROS1 , and RET gene fusions in in real life FFPE specimens of non-small cell lung cancers

Article Link

Year:

2023

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

Article Link

Year:

2023

Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture

Article Link

Year:

2023

Hyalinizing clear cell carcinoma of the lung with EWSR1::CREM fusion

Article Link

Year:

2023

How do I reach out?

Meet Kite AI

Fabien Forest

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles10

Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study

Abstract 1221: Selective translational activation of PBK (PDZ- binding kinase) reveals a molecular vulnerability of drug-tolerant persister cells to targeted therapies in <i>EGFR</i>-mutant lung adenocarcinoma

Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18F-FDG PET/CT

Spread Through Air Spaces in Stage I to III Resected Lung Adenocarcinomas

Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognizable by a specific epigenetic signature

Usefulness of an RNA extraction-free test for the multiplexed detection of <i>ALK</i> , <i>ROS1</i> , and <i>RET</i> gene fusions in in real life FFPE specimens of non-small cell lung cancers

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture

Hyalinizing clear cell carcinoma of the lung with <i>EWSR1::CREM</i> fusion

How do I reach out?

Fabien Forest

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles10

Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study

Abstract 1221: Selective translational activation of PBK (﻿PDZ- binding kinase) reveals a molecular vulnerability of drug-tolerant persister cells to targeted therapies in <i>EGFR</i>-mutant lung adenocarcinoma

Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18F-FDG PET/CT

Spread Through Air Spaces in Stage I to III Resected Lung Adenocarcinomas

Analysis of a pituitary tumour with histological features of central neurocytoma points towards the emergence of a new entity recognizable by a specific epigenetic signature

Usefulness of an RNA extraction-free test for the multiplexed detection of <i>ALK</i> , <i>ROS1</i> , and <i>RET</i> gene fusions in in real life FFPE specimens of non-small cell lung cancers

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture

Hyalinizing clear cell carcinoma of the lung with <i>EWSR1::CREM</i> fusion

How do I reach out?

Abstract 1221: Selective translational activation of PBK (PDZ- binding kinase) reveals a molecular vulnerability of drug-tolerant persister cells to targeted therapies in <i>EGFR</i>-mutant lung adenocarcinoma